da Admin | Lug 14, 2021 | Business, News, News
https://www.cellares.com Cellares Corporation (life sciences technology company) ha dichiarato che Poseida therapeutics (azienda biofarmaceutica) ha aderito al programma “Early Access Partnership Program (EAPP)” avviato nel 2020. L’obiettivo di EAPP è quello di...
da Admin | Set 14, 2021 | Archivio Eventi
14-16 Settembre 2021 | Evento digitale – EDT Scopri di più
da Admin | Apr 14, 2021 | Clinical
https://www.bionews.org.uk A clinical trial for a new gene therapy approach to treat sickle cell disease has been approved to proceed by the US Food and Drug Administration. Patients with sickle cell disease have a mutation in the β -haemoglobin gene, causing them to...
da Admin | Apr 14, 2021 | Clinica
https://www.bionews.org.uk Uno studio clinico relativo ad una nuova terapia genica per il trattamento dell’anemia falciforme è stato approvato dalla US Food and Drug Administration. L’anemia falciforme è una malattia genetica ereditaria causata da una mutazione a...
da Admin | Apr 14, 2021 | Business
https://ct.catapult.org.uk Recently GSK and Rentschler Biopharma SE announced they will expand existing and build new celltherapy genetherapy manufacturing capabilities at the CGT Catapult facility in Stevenage. The two companies will join other collaborators who are...